Difficulty: Medium
Average Score: 76%
Practice
This compound reduces the need for platelet transfusions in patients undergoing cancer chemotherapy
Correct answer
C
Rationale
In the context of ABVD chemotherapy, the correct answer to the question is C) Interleukin - II. Interleukin - II is a cytokine that stimulates the production of platelets in the body, thereby reducing the need for platelet transfusions in patients undergoing cancer chemotherapy. This is important because chemotherapy often leads to a decrease in platelet count, which can result in bleeding and other complications.
Option A) Cyanocobalamin is a form of vitamin B12 that is used to treat vitamin B12 deficiency and certain types of anemia, but it does not directly impact platelet production or the need for platelet transfusions in chemotherapy patients.
Option B) Erythropoietin is a hormone that stimulates red blood cell production and is used to treat anemia, particularly in patients with chronic kidney disease. It does not have a direct effect on platelet production.
Option D) Iron dextran is an iron supplement used to treat iron deficiency anemia by increasing iron levels in the body. While iron is essential for overall health, it does not specifically address the issue of platelet transfusions in cancer patients undergoing chemotherapy.
Educationally, understanding the mechanisms of different drugs and their specific effects on the body is crucial for healthcare professionals involved in the care of cancer patients. Knowing which medications can help alleviate specific symptoms or complications of chemotherapy can improve patient outcomes and quality of life. Interleukin - II's role in stimulating platelet production showcases the importance of targeted therapies in managing the side effects of cancer treatment.
Option A) Cyanocobalamin is a form of vitamin B12 that is used to treat vitamin B12 deficiency and certain types of anemia, but it does not directly impact platelet production or the need for platelet transfusions in chemotherapy patients.
Option B) Erythropoietin is a hormone that stimulates red blood cell production and is used to treat anemia, particularly in patients with chronic kidney disease. It does not have a direct effect on platelet production.
Option D) Iron dextran is an iron supplement used to treat iron deficiency anemia by increasing iron levels in the body. While iron is essential for overall health, it does not specifically address the issue of platelet transfusions in cancer patients undergoing chemotherapy.
Educationally, understanding the mechanisms of different drugs and their specific effects on the body is crucial for healthcare professionals involved in the care of cancer patients. Knowing which medications can help alleviate specific symptoms or complications of chemotherapy can improve patient outcomes and quality of life. Interleukin - II's role in stimulating platelet production showcases the importance of targeted therapies in managing the side effects of cancer treatment.